Ibrahim Alowidah

King Saud Medical City

Papers

1

Total Citations

19

H-Index

1

About

Dr. Ibrahim Alowidah is a urologic surgeon and researcher whose work focuses on advancing surgical techniques for prostate cancer treatment, particularly through comparative effectiveness research. His most notable contribution is a prospective comparative study evaluating Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) versus open retropubic radical prostatectomy (ORP), which has garnered 19 citations since its 2020 publication. This landmark work provides critical 19-month follow-up data demonstrating that RS-RARP offers comparable oncologic control with potential advantages in functional recovery, helping to establish robotic-assisted approaches as viable alternatives to traditional open surgery. Dr. Alowidah’s research addresses the pressing clinical question of optimizing surgical outcomes while minimizing patient morbidity, directly impacting urological practice guidelines. His work exemplifies the rigorous comparative methodology needed to validate emerging surgical technologies, making him a valuable contributor to evidence-based urologic oncology. For students and researchers, Dr. Alowidah’s studies highlight the importance of prospective trial design in evaluating surgical innovations and the ongoing evolution toward less invasive prostate cancer treatments.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Retzius-sparing robot-assisted radical prostatectomy versus open retropubic radical prostatectomy: a prospective comparative study with 19-month follow-up
19 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: King Saud Medical City

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago